Crude Oil Edges Lower; Lamb Weston Shares Surge Following Upbeat Q1 Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones index surging around 350 points on Tuesday. The Dow traded up 0.69% to 51,622.17 while the NASDAQ jumped 0.79% to 27,694.08. The S&P 500 also rose, gaining, 0.86% to 7,840.48. Leading and Lagging Sectors Utilities shares jumped by 1.9% on Tuesday. In trading on Tuesday, energy stocks fell by 0.4%. Top Headline Lamb Weston Holdings Inc (NYSE: LW ) shares jumped around 12% on Tuesday as the company reported better-than-expected first-quarter financial results and raised its FY27 guidance above estimates. Lamb Weston reported quarterly earnings of 75 cents per share which beat the analyst consensus estimate of 59 cents per share. The company reported quarterly sales of $1.670 billion which beat the analyst consensus estimate of $1.655 billion. Equities Trading UP Option Care Health Inc ( NASDAQ: OPCH ) shares shot up 33% to $31.05. CD&R and McKesson Corporation signed an agreement to acquire Option Care Health. Shares of XChange TEC.INC (NASDAQ: XHG ) got a boost, surging 77% to $3.37 after the company announced it intends to gradually reduce operations in Mainland China and plans to invest between $5 million and $10
S. stocks traded higher midway through trading, with the Dow Jones index surging around 350 points on Tuesday. 08. 48.
9% on Tuesday. 4%. Top Headline Lamb Weston Holdings Inc (NYSE: LW ) shares jumped around 12% on Tuesday as the company reported better-than-expected first-quarter financial results and raised its FY27 guidance above estimates. Lamb Weston reported quarterly earnings of 75 cents per share which beat the analyst consensus estimate of 59 cents per share.
655 billion. 05. CD&R and McKesson Corporation signed an agreement to acquire Option Care Health. S.
Market. 32 after the company announced a long-term strategic clean energy collaboration with Google to bring 890 megawatts of new nuclear capacity onto the PJM Interconnection grid. 82 as the company said Says Phase 3 trial of firmonertinib in EGFR Exon 20 lung cancer missed primary progression-free survival endpoint. 95.
Vaxcyte announced $500 million equity offering and $500 million convertible notes offering. 0 million public offering of common stock. 60. 6170.
Euro zone European shares were higher today. 3%. 95%. S.
0 billion and recording its largest deficit since March 2025. S. 8 billion in August. Photo via Shutterstock